1. Home
  2. PNTG vs AVXL Comparison

PNTG vs AVXL Comparison

Compare PNTG & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNTG
  • AVXL
  • Stock Information
  • Founded
  • PNTG 2019
  • AVXL 2004
  • Country
  • PNTG United States
  • AVXL United States
  • Employees
  • PNTG N/A
  • AVXL N/A
  • Industry
  • PNTG Medical/Nursing Services
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PNTG Health Care
  • AVXL Health Care
  • Exchange
  • PNTG Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • PNTG 829.8M
  • AVXL 956.7M
  • IPO Year
  • PNTG N/A
  • AVXL N/A
  • Fundamental
  • Price
  • PNTG $24.55
  • AVXL $8.90
  • Analyst Decision
  • PNTG Buy
  • AVXL Strong Buy
  • Analyst Count
  • PNTG 6
  • AVXL 2
  • Target Price
  • PNTG $35.00
  • AVXL $44.00
  • AVG Volume (30 Days)
  • PNTG 362.9K
  • AVXL 968.5K
  • Earning Date
  • PNTG 11-05-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • PNTG N/A
  • AVXL N/A
  • EPS Growth
  • PNTG 20.56
  • AVXL N/A
  • EPS
  • PNTG 0.77
  • AVXL N/A
  • Revenue
  • PNTG $798,923,000.00
  • AVXL N/A
  • Revenue This Year
  • PNTG $28.29
  • AVXL N/A
  • Revenue Next Year
  • PNTG $11.61
  • AVXL N/A
  • P/E Ratio
  • PNTG $32.65
  • AVXL N/A
  • Revenue Growth
  • PNTG 30.58
  • AVXL N/A
  • 52 Week Low
  • PNTG $21.18
  • AVXL $5.03
  • 52 Week High
  • PNTG $37.13
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • PNTG 48.52
  • AVXL 51.06
  • Support Level
  • PNTG $23.68
  • AVXL $8.82
  • Resistance Level
  • PNTG $26.11
  • AVXL $9.69
  • Average True Range (ATR)
  • PNTG 0.79
  • AVXL 0.48
  • MACD
  • PNTG 0.03
  • AVXL -0.50
  • Stochastic Oscillator
  • PNTG 37.40
  • AVXL 85.48

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: